Financial Performance - The company reported a total revenue of RMB 500 million for the first half of 2023, representing a year-on-year increase of 20%[1]. - The company's operating revenue for the first half of 2023 was ¥779,244,885.55, a decrease of 1.79% compared to the same period last year[20]. - The net profit attributable to shareholders was ¥33,019,126.53, down 46.98% year-on-year, primarily due to a decline in gross margin and increased expenses[22]. - The net cash flow from operating activities was -¥30,222,902.42, a decrease of ¥66,211,958.77 compared to the previous year[23]. - The company's total assets at the end of the reporting period were ¥2,425,314,763.25, a decrease of 4.59% from the end of the previous year[23]. - The net assets attributable to shareholders increased by 0.63% to ¥1,506,889,289.30 compared to the end of the previous year[23]. - Basic earnings per share decreased by 47.06% to ¥0.27, while diluted earnings per share decreased by 52.94% to ¥0.24[21]. - The net profit after deducting non-recurring gains and losses was ¥26,559,224.20, down 51.75% year-on-year[22]. Market Expansion and Strategy - The company expects a revenue growth forecast of 25% for the second half of 2023, driven by new product launches and market expansion strategies[1]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2024[1]. - A strategic acquisition of a local competitor is under consideration to enhance production capabilities and market reach[1]. - The company is actively promoting its organic sludge dewatering agent to support the transition from landfill to land utilization for sludge disposal[32]. - The company is focusing on expanding its overseas business, achieving sales growth in the North American market for water-soluble polymers[66]. Research and Development - Research and development expenses increased by 30%, totaling RMB 50 million, focusing on new water treatment membrane technologies[1]. - The research and development expenditure accounted for 4.37% of operating revenue, a decrease of 0.21 percentage points year-on-year[21]. - The company has developed 22 core technologies across various fields, including functional monomer manufacturing and water treatment membranes[44]. - The company has 16 ongoing research projects and has obtained 20 new patents during the reporting period, including 11 invention patents and 9 utility model patents, bringing the total number of authorized patents to 230[50]. - The company is focusing on high-performance and new product development to meet the increasing demands from downstream industries[31]. Product Development and Innovation - The company has introduced two new products in the water treatment sector, projected to contribute an additional RMB 100 million in revenue by year-end[1]. - The company has developed a new water-soluble polymer manufacturing technology for solid anionic polyacrylamide, focusing on ultra-high molecular weight production[48]. - The company has achieved a separation rate of over 98% for divalent salts and less than 30% for monovalent salts using its special polyamide nanofiltration membrane technology[47]. - The company has developed a proprietary technology for producing high-temperature and high-salt resistant polymers, with 4 invention patents granted[14]. - The company has developed salt-resistant products in oilfield chemicals, which have entered the trial production stage[56]. Competitive Landscape - The company is facing intense competition in the water treatment membrane market, with high-end products still heavily reliant on imports[30]. - The domestic water-soluble polymer industry is undergoing consolidation, with the number of manufacturers decreasing from nearly 200 to about 30, indicating a rise in industry concentration[29]. - The company’s market share in the paper-making polyacrylamide sector is leading, while cationic polyacrylamide products consistently rank in the top five of the industry[36]. - The company is exposed to risks from intensified market competition in the functional monomer and water treatment chemical sectors[80]. Environmental and Safety Management - The company has achieved zero wastewater discharge through the upgrade of the wastewater treatment station, ensuring stable operation of the water reuse and zero discharge systems[123]. - The company has installed automatic monitoring equipment for nitrogen oxides, sulfur dioxide, and particulate matter at major emission points, effectively monitoring air pollutant emissions[124]. - The company has implemented energy-saving measures, including the replacement of low-efficiency motors with high-efficiency ones, resulting in a reduction of 1,097 tons of CO2 equivalent emissions[132]. - The company has established an emergency response plan for environmental incidents, which has been filed with the local environmental emergency response center[127]. Shareholder Commitments and Governance - The company commits to a stable profit distribution policy, ensuring cash dividends of no less than 10% of the distributable profit each year[176]. - The company will publicly disclose reasons for any failure to fulfill commitments and apologize to shareholders and the public[183]. - The company has established measures to stabilize its stock price, including potential buybacks if the stock price falls below the audited net asset value for 20 consecutive trading days[161]. - The company will not engage in public refinancing if it fails to fulfill commitments, and responsible executives may face salary reductions[183]. - The company guarantees that 富淼科技 will independently conduct research, production, and sales of functional monomers, water-soluble polymers, and water treatment membranes, serving as the sole entity in this field[148].

| 证券代码：688350 | 证券简称：富淼科技 | 公告编号：2023-055 | | --- | --- | --- | | 转债代码：118029 | 转债简称：富淼转债 | | 江苏富淼科技股份有限公司（以下简称"公司"）证券事务代表孙海燕女士 因个人原因申请辞去公司证券事务代表职务，孙海燕女士辞职后不再担任公司任 何职务。孙海燕女士在担任公司证券事务代表期间勤勉尽责、恪尽职守，公司董 事会对其在任职期间所做出的贡献表示衷心感谢。 公司于 2023 年 8 月 17 日召开第五届董事会第九次会议，审议通过了《关于 变更证券事务代表的议案》，同意聘请顾宇轩先生（个人简历附后）为公司证券 事务代表，协助董事会秘书开展日常工作，任职期限自本次董事会审议通过之日 起至第五届董事会届满之日止。顾宇轩先生获聘后，尚需取得上海证券交易所科 创板董事会秘书资格证书，承诺将参加近期上海证券交易所科创板董事会秘书任 前培训。顾宇轩先生具备担任证券事务代表所必需的相关素质与工作经验，其任 职资格符合《中华人民共和国公司法》《上海证券交易所科创板股票上市规则》 等相关法律法规和规范性文件的规定。 公司证券事务代表联系方式如 ...

综上，我们一致同意本次 2023 年半年度募集资金存放与使用情况的事项。 2、《关于会计估计变更的议案》的独立意见 1、《关于公司 2023 年半年度募集资金存放与使用情况的专项报告的议案》 的独立意见 公司编制的 2023 年半年度募集资金存放与使用情况的专项报告，募集资金 的审核程序符合《上市公司监管指引第 2 号—上市公司募集资金管理和使用的监 管要求》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 等相关法律法规的要求。公司对募集资金进行了专户存储和专项使用，及时履行 了相关信息披露义务，募集资金具体使用情况与公司披露情况一致，不存在变相 改变募集资金用途和损害股东利益的情况，不存在违规使用募集资金的情况。 江苏富淼科技股份有限公司独立董事 独立董事认为，公司本次会计估计变更符合《企业会计准则第 28 号——会 计政策、会计估计变更和差错更正》的相关规定和公司实际经营情况。变更后的 会计估计能更准确反映公司财务情况和经营成果，不存在损害公司股东特别是中 小股东利益的情形。本次会计估计变更的审议程序符合《公司法》等有关法律法 规及《公司章程》的规定。 关于公司第五届董事会第九次会议相 ...

关于江苏富淼科技股份有限公司 会计估计变更的鉴证报告 中国杭州市钱江新城新业路8号UDC时代大厦A座5-8层、12层、23层 Floors 5-8, 1.2 and 23, Block A, UDC Times Building, No. 8 Xinye Road, Qianjiang New City, Hangzhou Tel. 0571-88879999 Fax. 0571-88879000 www.zhcpa.cn 同及 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://acc.mof.eov.cn）"进行查验 报告编码:浙23AV5 目 - 录 www.zhcpa.cn 关于江苏富淼科技股份有限公司 会计估计变更的鉴证报告 中汇会鉴[2023]8544号 江苏富淼科技股份有限公司全体股东: 我们鉴证了后附的江苏富淼科技股份有限公司(以下简称富淼科技公司)管理 层编制的《江苏富淼科技股份有限公司会计估计变更的说明》(以下简称会计估计 变更的说明)。 一、对报告使用者和使用目的限定 | | 页 次 | | --- | --- | | 一、会计估计变更的鉴证报告 | 1-2 | | ...

| 证券代码：688350 | 证券简称：富淼科技 | 公告编号：2023-054 | | --- | --- | --- | | 转债代码：118029 | 转债简称：富淼转债 | | 江苏富淼科技股份有限公司 关于会计估计变更的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 2023 年 8 月 17 日，公司召开第五届董事会第九次会议、第五届监事会第八 次会议，审议通过了《关于会计估计变更的议案》，公司独立董事对该项议案发 表了同意的独立意见。本次会计估计变更事项无需提交公司股东大会审议。具体 1 根据《企业会计准则第 28 号——会计政策、会计估计变更和差错更正》 的相关规定，江苏富淼科技股份有限公司（以下简称"公司"）本次会计估计 变更采用未来适用法进行相应的会计处理，无需对公司已披露的财务报表进 行追溯调整，对以往各年度财务状况和经营成果不会产生影响。 公司自 2023 年 4 月 1 日起变更应收票据和应收账款预期信用损失率，公 司基于2023年6月30日应收票据和应收账款余额及账龄基础 ...

证券代码：688350 证券简称：富淼科技 公告编号：2023-052 转债代码：118029 转债简称：富淼转债 江苏富淼科技股份有限公司 2023年半年度募集资金存放与使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要 求》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有 关法律法规的规定并结合公司实际情况，江苏富淼科技股份有限公司（以下简称 "公司"或"富淼科技"）董事会对 2023 年半年度募集资金存放和实际使用情况 专项报告说明如下： 一、募集资金基本情况 （一）募集资金金额和资金到账时间 1、首次公开发行股票募集资金基本情况 2 单位：人民币万元 序 号 项 目 金 额 1 2021 年 1 月 25 日实际到账的募集资金 38,401.51 2 减：支付的发行有关的直接相关费用（包括自筹资金预先支付 发行费用置换金额）[注] 1,709.19 3 减：以自筹资金预先投入募集资金投资项目置换金额 2,3 ...

江苏富淼科技股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 会议召开时间：2023 年 08 月 28 日(星期一) 下午 14:00-15:00 证券代码：688350 证券简称：富淼科技 公告编号：2023-056 转债代码：118029 转债简称：富淼转债 ● 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） ● 会议召开方式：上证路演中心网络互动 ● 投资者可于 2023 年 08 月 21 日(星期一) 至 08 月 25 日(星期五)16:00 前登 录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 IR@feymer.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 江苏富淼科技股份有限公司（以下简称"公司"）已于 2023 年 8 月 18 日发 布公司 2023 年半年度报告，为便于广大投资者更全面深入地了解公司 2023 年度 半年度经营 ...

证券代码：688350 证券简称：富淼科技 公告编号：2023-053 转债代码：118029 转债简称：富淼转债 江苏富淼科技股份有限公司 二、监事会会议审议情况 第五届监事会第八次会议决议公告 本公司监事会及全体监事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 江苏富淼科技股份有限公司（以下简称"公司"）第五届监事会第八次会议 于2023年8月17日在公司会议室采用现场会议与通讯会议相结合的方式召开。本 次会议应出席会议监事3名，实际出席会议监事3名。会议由监事会主席周汉明先 生召集并主持，会议的召集和召开符合《中华人民共和国公司法》等法律、法规 和《江苏富淼科技股份有限公司章程》的有关规定，合法有效。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 具体内容详见公司同日披露于上海证券交易所网站（www.sse.com.cn）的《江 苏富淼科技股份有限公司 2023 年半年度募集资金存放与使用情况的专项报告》 （公告编号：2023-052）。 2、审议通过《关于公司 2023 年半年度报告及其摘要的议案》 经审 ...

证券代码：688350 证券简称：富淼科技 公告编号：2023-035 转债代码：118029 转债简称：富淼转债 江苏富淼科技股份有限公司 关于召开 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 会议召开时间：2023 年 05 月 30 日(星期二) 上午 09:00-10:00 本次投资者说明会以网络互动形式召开，公司将针对 2022 年度的经营成果 及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围内 就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 （一） 会议召开时间：2023 年 05 月 30 日 上午 09:00-10:00 （二） 会议召开地点：上证路演中心 （三） 会议召开方式：上证路演中心网络互动 ● 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） ● 会议召开方式：上证路演中心网络互动 ● 投资者可于 2023 年 05 月 23 日(星期二) 至 0 ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 371,485,658.61, representing a decrease of 1.70% compared to the same period last year[5]. - The net profit attributable to shareholders was CNY 13,469,365.96, down 51.64% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 56.26% to CNY 10,452,199.51[10]. - Basic earnings per share were CNY 0.11, a decline of 52.17% compared to the previous year[6]. - Net profit for Q1 2023 was CNY 11,636,531.02, down 58.24% compared to CNY 27,852,502.07 in Q1 2022[21]. - The operating profit for Q1 2023 was ¥17.9 million, a decline of 42.5% from ¥31.1 million in Q1 2022[30]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,455,192,111.40, down 3.41% from the end of the previous year[6]. - As of March 31, 2023, total assets amounted to CNY 2,455,192,111.40, a decrease from CNY 2,541,979,768.60 at the end of 2022, reflecting a decline of approximately 3.4%[16]. - Current assets totaled CNY 1,495,194,987.34, down from CNY 1,617,887,988.20, indicating a decrease of about 7.5%[17]. - Total liabilities as of Q1 2023 amounted to CNY 859,418,529.96, down from CNY 960,596,929.18 in the previous year[19]. - The total liabilities decreased to 742,993,125.08 RMB from 805,645,658.27 RMB, indicating a reduction of approximately 7.77%[27]. Cash Flow - The net cash flow from operating activities was CNY -46,025,592.56, indicating a significant cash outflow[5]. - The company's cash flow from operating activities showed a significant increase, indicating improved operational efficiency despite a decline in net profit[24]. - Cash inflow from operating activities totaled CNY 333,361,900.53, compared to CNY 276,780,086.46 in Q1 2022, reflecting a growth of 20.41%[24]. - The cash flow from operating activities showed a net outflow of ¥28.2 million in Q1 2023, compared to a net inflow of ¥10.8 million in Q1 2022[33]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 5,525[12]. - The company reported a total of 10,779,977 shares held by Beijing Ruishi Bang Fine Chemical Technology Co., Ltd., making it the largest unrestricted shareholder[14]. - The second-largest shareholder, Jiang Feng, holds 2,915,595 shares, representing 2.39% of the total shares[14]. Research and Development - Research and development expenses totaled CNY 15,669,388.94, accounting for 4.22% of operating revenue, a decrease of 0.2 percentage points[6]. - Research and development expenses decreased to ¥8.7 million in Q1 2023, down 28.5% from ¥12.2 million in Q1 2022[29]. Investment Activities - The company has ongoing investments in new technologies and products, although specific details were not disclosed in the report[15]. - Cash inflow from investment activities was 299,683,357.42 RMB, compared to 281,446,119.03 RMB in the previous year, marking an increase of 6.4%[25]. - Cash outflow from investment activities totaled 426,745,379.32 RMB, up from 316,501,365.24 RMB, representing a significant increase of 34.8%[25]. - The company raised 23,317,380.00 RMB from new investments, compared to no new investments in the previous year[25]. Financial Expenses - The company reported a financial expense of CNY 1,853,988.48 in Q1 2023, compared to a financial income of CNY 135,412.73 in Q1 2022[20]. - The company reported a significant increase in financial expenses, with interest expenses rising to ¥2.6 million in Q1 2023 from ¥0.1 million in Q1 2022[29].